In vivo Response of Bioactive PMMA-based Bone Cement Modified with Alkoxysilane and Calcium Acetate

• Published in: Journal of biomaterials applications 2008-11, Vol.23 (3), p.213-228
• Main Authors: Sugino, Atsushi, Ohtsuki, Chikara, Miyazaki, Toshiki
• Format: Article
• Language: English
• Subjects: Acetates - chemistry; Alcohols - chemistry; Animals; Bone Cements - chemistry; Bone Cements - therapeutic use; Calcium Compounds - chemistry; Fracture Healing - drug effects; Male; Materials Testing; Polymethyl Methacrylate; Rabbits; Silanes - chemistry; Tibial Fractures - pathology; Tibial Fractures - therapy; Treatment Outcome
• ISSN: 0885-3282; 1530-8022
• DOI: 10.1177/0885328207081694

The use of polymethylmethacrylate (PMMA)-based bone cement is popular in orthopedics for the fixation of artificial joints with bone. However, it has a major problem with prostheses loosening because of coverage by fibrous tissue after long-term implantation. Recently, a bioactive bone cement has been developed that shows direct bonding to living bone through modification of PMMA resin with γ-methacryloxypropyltrimethoxysilane (MPS) and calcium acetate. The cement is designed to exhibit bioactivity, through incorporation of silanol groups and calcium ions. Thus, it has the potential to form a layer of bone-like hydroxyapatite, which is essential for achieving direct bonding to living bone. This type of modification allows the cement to show spontaneous hydroxyapatite formation on its surface in a simulated body fluid after one day, and there is evidence of osteoconduction of the cement in rabbit tibia for periods of more than three weeks. However, the influence of the dissolved ions from the modified cement has not yet been clarified. Thus, the authors focused on the dissolution of the modified PMMA-based bone cement and its tissue response in muscle and bone by comparison with the behavior of non-modified PMMA-based bone cement. One week after implantation in the latissimus dorsi of a rabbit, the modified PMMA-based bone cement showed more inflammatory width than the commercial cement. However, four weeks after implantation, the inflammatory width of both cements was essentially the same. The osteoconductivity around the modified cement was higher than that for the conventional cement after four weeks implantation. These results indicate that the initial dissolution of calcium acetate from the modified cement to form the hydroxyapatite induced the acute inflammation around tissue, but also developed the osteoconductivity. It is suggested that the initial inflammation can be effective for inducing osteoconduction through a bone healing reaction when the material provides an environment that promotes bone formation.